F7 and hemophilia A: Decreased factor VIII activity (3.4%, reference range: 60-140%) and positive factor VIII inhibitors (9.2 Bethesda Units/mL) were detected, and he was diagnosed with acquired hemophilia A. Recombinant activated factor VII and high-dose steroid treatment was initiated to improve severe bleeding symptoms.